BIIB.US stock price

Biogen

168.08 USD

-0.54 (-0.32%)

1MN

BIIB.US Key Statistics

Open price

168.9

High today

169.39

Low today

166.57

52 Week high

189.73

52 Week low

109.78

Trading hours

-12:00

-11:00

-10:00

-09:00

-08:00

-07:00

-06:00

-05:00

-04:00

-03:00

-02:00

-01:00

UTC 00:00

+01:00

+02:00

+03:00

+03:30

+04:00

+04:30

+05:00

+05:30

+05:45

+06:00

+07:00

+08:00

+09:00

+09:30

+10:00

+11:00

+12:00

+12:45

+13:00

+14:00

UTC 00:00

Symbol trading specification

Trade Biogen

About BIIB.US

The Biogen (BIIB.US) stock price presents the company’s significant contributions to medical research and its impact on the biotechnology industry.

What is Biogen?

Biogen is focused on developing innovative therapies for serious neurological and neurodegenerative diseases, with a robust pipeline that includes treatments for multiple complex conditions. Users of SimpleFX who are interested in how to trade BIIB.US and other assets listed on the NASDAQ and S&P500 can start with a demo account. This feature provides a risk-free environment in which to practice trading American equities. The SimpleFX live account gives access to no minimum deposit, no commissions, and leverage options alongside multiple other features.

Current BIIB.US stock price

The BIIB.US stock price reflects the market valuation of Biogen, a biotechnology company focused on neurological diseases. The live BIIB.US price is available on the SimpleFX website or Webtrader platform.

How does Biogen work?

Trading Biogen on SimpleFX allows investors to engage with a company that is at the cutting edge of neurological research. BIIB.US is part of a broad array of equities from various countries and time zones in the platform’s portfolio. Biogen stock price depends on clinical trial outcomes, FDA approvals, research and development advancements, and partnerships or acquisitions that expand its therapeutic portfolio. Learning how to invest in BIIB.US is crucial for traders looking to understand the medical science market.

BIIB.US chart

The BIIB.US chart captures Biogen’s market activity, with indicators enabling structured technical evaluation. The Biogen chart is accessible in a demo account that mirrors the same tools as the full version.

Biogen stock price history

Biogen stock price history is characterized by its responsiveness to clinical trial results and regulatory milestones, which can lead to significant fluctuations. The company’s innovative approach to treating complex diseases has driven investor interest, particularly in light of its pioneering efforts in Alzheimer’s disease treatment.

BIIB.US market cap

Biogen market cap emphasizes its stature within the biotechnology sector, particularly in neuroscience. The BIIB.US market cap is a key indicator of its market influence and financial stability, highlighting its role as a leader in advancing treatment for some of the most challenging medical conditions.